Melbourne medical device company Cylite has unveiled its soon-to-be-released HP-OCT to an international audience at the Association for Research in Vision and Ophthalmology (ARVO) conference in Denver, Colorado.
Held in May, the ARVO conference is primarily aimed at both clinical and basic researchers in the field of vision, with the aim to advance research into the visual system and ultimately address visual disorders.
Apart from generating interest as an exhibitor, Cylite’s HP-OCT was also featured through the research of two international institutions: the University of California, Los Angeles (UCLA) and Stanford University.
Associate Professor Edmund Tsui and Ms Nina Cherian from UCLA presented a poster titled ‘Comparison of a novel hyper-parallel optical coherence tomography biometer with a swept source OCT biometer in patients with cataracts’, which compared biometric parameters generated by Cylite’s HP-OCT to those of a commercially available optical biometer.
Additionally, Stanford’s Associate Professor Alfredo Dubra and optics PhD candidate Ms Grayce Huang presented a poster titled ‘Retinal magnification factors derived from refraction-corrected optical biometry’.
“This research utilised the unique capabilities of Cylite’s HP-OCT to quantify the anterior and posterior surfaces of the cornea and crystalline lens, plus the distances between each surface, and then used ray tracing to take into account the magnification of individual eyes,” a Cylite spokesperson said.
“By doing this, the authors were able to more faithfully describe the proportions of the retina of each individual eye, which could be important for the measurement of retinal structures using OCT.”
Cylite has confirmed the first public showing of its Australian-made HP-OCT with Focus software will take place at O-Show in Sydney this week, with a European launch scheduled for the first quarter of 2023.